Boston Scientific (BSX) Interest Expenses (2009 - 2026)

Boston Scientific has disclosed Interest Expenses across 18 years of filings, most recently posting $96.0 million for Q2 2026.

• In Q2 2026, Interest Expenses rose 6.67% year-over-year to $96.0 million; the TTM figure through Jun 2026 stood at $363.0 million (up 9.67% YoY), while the FY2025 annual figure was $349.0 million, up 14.43% from the prior year.
• Interest Expenses came in at $96.0 million for Q2 2026 at Boston Scientific, up from $90.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $279.0 million in Q1 2022 to a low of $63.0 million in Q3 2022.
• Average Interest Expenses over 5 years is $87.6 million, with a median of $78.0 million recorded in 2024.
• Year-over-year, Interest Expenses soared 240.24% in 2022 and slumped 76.7% in 2023.
• Over 5 years, Interest Expenses stood at $64.0 million in 2022, then gained by 1.56% to $65.0 million in 2023, then rose by 23.08% to $80.0 million in 2024, then climbed by 12.5% to $90.0 million in 2025, then rose by 6.67% to $96.0 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $96.0 million in Q2 2026, $90.0 million in Q1 2026, and $90.0 million in Q4 2025.